Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Ovarian Neoplasms 2 Sarcoma 1 Radiation Pneumonitis 1 Pancreatic Neoplasms 1 Mesothelioma, Malignant 1 Mesothelioma 1 Inflammatory Breast Neoplasms 1 Glioblastoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Appendiceal Neoplasms 1

Interventions

Pemetrexed 9 Cisplatin 9 pembrolizumab 5 defactinib 3 Cyclophosphamide 3 sodium thiosulfate 2 Radiotherapy, Intensity-Modulated 2 Platinum 2 Immunoenzyme Techniques 2 Doxorubicin 2 1,2-diaminocyclohexaneplatinum II citrate 2 vatalanib 1 spartalizumab 1 osimertinib 1 nintedanib 1 liposomal doxorubicin 1 cabozantinib 1 antineoplaston AS 2-1 1 antineoplaston A10 1 amatuximab 1 alvocidib 1 aldesleukin 1 X-Rays 1 VS-5584 1 Trabectedin 1 Tetrahydrouridine 1 Specimen Handling 1 Ramucirumab 1 Radiotherapy 1 Radiation Dose Hypofractionation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Mesothelioma, Malignant × nintedanib × Clear all

NCT02863055 2025-09-19

NEMO

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡